2m 2m 2m 2m 2m 2m 2m
ADC Therapeutic N (ADCT)
NYSE
$1.58+$0.08 (+5.33%)
Price as of Oct 22, 2026 7:33 PM EDT- $211.8MMarket Cap
- -63.14%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ADC Therapeutic N (ADCT)
$1.58+$0.08 (+5.33%)
ADCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.50 | ||
Change | -$0.02 (-1.32%) | ||
Open | $1.53 | ||
High | $1.55 | ||
Low | $1.44 | ||
Previous Close | $1.52 | ||
Volume | 1,328,331 | ||
30-Day Average Volume | 1,670,141 | ||
1-Week Change | 3.45% | ||
1-Month Change | 33.93% | ||
1-Year Change | -63.14% | ||
3-Year Change | 80.72% | ||
5-Year Change | -94.32% | ||
Fundamentals | |||
Shares Outstanding | 141.2M | ||
Total Assets | $279.4M | ||
Market Cap | $211.8M | ||
Enterprise Value | $109.3M | ||
Period: QTR TTM FY | |||
Revenue | $19.2M | ||
Net Income | -$16.6M | ||
Free Cash Flow | -$11.8M | ||
EBIT | -$12.2M | ||
EBITDA | -$12.2M | ||
Net Working Capital | $175.4M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 6 | ||
P/B | -1 | ||
P/E | -14 | ||
PEG | -0 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/10/2005 | ||
Earnings & Revenue